Table Of Content

Clinica Chimica Acta, Vol. 193 Author index Akaoka, I., see Kaneko, K. (193) 181 Mass concentration measurements of creatine Amouyel, P., see Gairin, D. (193) 165 kinase BB isoenzyme as an index of brain Anandaraj, M.P.J.S., see Jagadeesh, G. (193) 79 tissue damage (193) 125 Anjaneyulu, A., see Jagadeesh, G. (193) 79 Deloly, J., see Maurel, E. (193) 27 Arino, Y., see Suiko, M. (193) 193 De Praeter, C., see Delanghe, J.R. (193) 125 Azema, C., see Maurel, E. (193) 27 De Winter, H.A., see Delanghe, J.R. (193) 125 Drosdowsky, M.A., see Foucault, P. (193) 91 Backer, E.T., see Harff, G.A. (193) 157 Duriez, P., see Gairin, D. (193) 165 Bard, J.-M., see Gairin, D. (193) 165 Bouissou, H., see Maurel, E. (193) 27 Eisenbeis, Jr., C.H., see Carpenter, A.B. (193) 1 Bouma, B.N., see De Bruin, T.W.A. (193) 137 Erkelens, D.W., see De Bruin, T.W.A. (193) 137 Brown, J.E. and Wahle, K.W_J. Effect of fish-oil and vitamin E supplementa- Fairney, A., see Straffen, A.M. (193) 55 tion on lipid peroxidation and whole-blood Fernando, P.H.P., see Suiko, M. (193) 193 aggregation in man (193) 147 Foucault, P. and Drosdowsky, M.A. Differential diagnosis of an hyperamylasemia Cachera, C., see Gairin, D. (193) 165 in an acute abdominal syndrome (193) 91 Camaert, J.J., see Delanghe, J.R. (193) 125 Friman, C., see Konttinen, Y.T. (193) 39 Cantwell, B.M.J., see Thompson, S. (193) 13 Fruchart, J.-C., see Gairin, D. (193) 165 Carmichael, D.J.S., see Straffen, A.M. (193) 55 Fujimori, S., see Kaneko, K. (193) 181 Carpenter, A.B., Huczko, E., Eisenbeis, Jr.. C.H. and Kelly, R.H. Gairin, D., Monard, F., Cachera, C., Bard, J.-M., Evidence for locally synthesized and clonally Amouyel, P., Duriez, P., Tacquet, A. and restricted immunoglobulin in the synovial Fruchart, J.-C. fluid from rheumatoid arthritis patients (193) Lipoprotein particles in homozygous familial 1 hyperchol lemic patients treated with Carroll, J.E., McGuire,, B.S., Hartlage, P.L. and portacaval shunt and LDL apheresis (193) Howard, J.C. 165 Decreased muscle enoyl-CoA hydratase activ- Grimm, U., see Petruschka, L. (193) 65 ities in patients with exercise intolerance (193) 89 Hara, I., see Takizawa, A. (193) 85 Chen, P.T. and Chen, S.S.-H. Harff, G.A. and Backer, E.T. Radial immunodiffusion and immunoe- Redox electrode for monitoring oxidase- lectrophoresis compared for identifying auto- catalyzed reactions (193) 187 Chen, S.S.-H., see Chen, P.T. (193) 187 antibodies to lactate dehydrogenase in human serum (193) 157 De Bruin, T.W.A., Vos, M.C., Kortlandt, W., Hartlage, P.L., see Carroll, J.E. (193) 89 Bouma, B.N. and Erkelens, D.W. Hatch, M. Proteolysis of human apolipoprotein B: effect Spectrophotometric determination of oxalate on quantitative i turbidi y (193) in whole blood (193) 199 137 Herkner, K.R., see Tsaka, T. (193) 103 De Buyzere, M.L., see Delanghe, J.R. (193) 125 Herrmann, F.H., see Petruschka, L. (193) 65 Delanghe, J.R., De Winter, H.A., De Buyzere, Hesselmans, L.F.G.M., see Wolthers, B.G. (193) M.L., Camaert, J.J., Martens, F.E. and 113 De Praeter, C. Hokari,, S., see Takizawa, A. (193) 85 204 Honkanen, V.E.A., see Konttinen, Y.T. (193) 39 tein in different human cells and tissues (193) Howard, J.C., see Carroll, J.E. (193) 89 65 Huczko, E., see Carpenter, A.B. (193) 1 Hulme, B., see Straffen, A.M. (193) 55 Raedsch, R., Stiehl, A., Walker, S., Theilmann, L., Kommerell, B., Waldherr, R. and Senn, Ishizuka, I., see Kaneko, K. (193) 181 M. Biliary excretion of iron in healthy man and Jagadeesh, G., Lavanya, M., Anandaraj, M.P.J.S. in patients with alcoholic cirrhosis of the liver and Anjaneyulu, A. (193) 49 Altered protein kinase C and protein kinase Rebrin, I., see Petruschka, L. (193) 65 A activities in erythrocyte membrane, plate- lets and lymphocytes of Duchenne muscular Saari, H., see Konttinen, Y.T. (193) 39 dystrophy (DMD) patients (193) 79 Sakagishi, Y., see Takizawa, A. (193) 85 Senn, M., see Raedsch, R. (193) 49 Kaneko, K., Fujimori, S., Ishizuka, I. and Snell, M.E., see Straffen, A.M. (193) 55 Akaoka, I. Stankovic¢, B.S., see Karljikovié-Raji¢é, K.D. (193) Effect of ethanol on metabolism of the hypo- 119 uricemic agents allopurinol and benzbrom- Stiehl, A., see Raedsch, R. (193) 49 arone (193) 181 Straffen, A.M., Carmichael, D.J.S., Fairney, A., Karljikovié-Raji¢é, K.D. and Stankovic¢, B.S. Hulme, B. and Snell, M.E. Use of pralidoxime-Pd(II) complex for the Studies of circulating parathyroid hormone spectrophotometric determination of the following parathyroidectomy in renal osteo- cholinesterase reactivator (PAM-2Cl) in the dystrophy (193) 55 urine (193) 119 Suiko, M., Fernando, P.H.P., Arino, Y., Terada, Kelly, R.H., see Carpenter, A.B. (193) 1 M., Nakatsu, S. and Liu, M.-C. Kommerell, B., see Raedsch, R. (193) 49 Quantitation of tyrosine-O-sulfate in human Komoda, T., see Takizawa, A. (193) 85 urine by ion-pair reverse-phase high-perfor- Konttinen, Y.T., Saari, H., Honkanen, V.E.A., mance liquid chromatography (193) 193 Szocsik, K., Mussalo-Rauhamaa, H., Tulen- Szocsik, K., see Konttinen, Y.T. (193) 39 salo, R. and Friman, C. Serum baseline hyaluronate and disease ac- Tacquet, A., see Gairin, D. (193) 165 tivity in rheumatoid arthritis (193) 39 Takizawa, A., Komoda, T., Hokari,, S., Sakagishi, Kortlandt, W., see De Bruin, T.W.A. (193) 137 Y., Tanaka, A. and Hara, I. Evaluation of the particle size distribution of Lavanya, M., see Jagadeesh, G. (193) 79 plasma lipoprotein in a patient with Tangier Liu, M.-C., see Suiko, M. (193) 193 disease by high performance liquid chromatography (193) 85 Martens, F.E., see Delanghe, J.R. (193) 125 Tanaka, A., see Takizawa, A. (193) 85 Maurel, E., Azema, C., Deloly, J. and Bouissou, Terada, M., see Suiko, M. (193) 193 H. Theilmann, L., see Raedsch, R. (193) 49 Collagen of the normal and the varicose hu- Thompson, S., Wong, E., Cantwell, B.M.J. and man saphenous vein: a biochemical study Turner, G.A. (193) 27 Serum alpha-l-proteinase inhibitor with McGuire,, B.S., see Carroll, J.E. (193) 89 abnormal properties in ovarian cancer (193) Monard, F., see Gairin, D. (193) 165 13 Mussalo-Rauhamaa, H., see Konttinen, Y.T. Tsaka, T. and Herkner, K.R. (193) 39 Polymorphonuclear elastase in neonatal sepsis (193) 103 Nakatsu, S., see Suiko, M. (193) 193 Tulensalo, R., see Konttinen, Y.T. (193) 39 Turner, G.A., see Thompson, S. (193) 13 Petruschka, L., Rebrin, I., Grimm, U. and Herr- mann, F.H. Van der Molen, J.C., see Wolthers, B.G. (193) The immunological evidence for a phenyl- 113 alanine hydroxylase like immunoreactive pro- Vos, M.C., see De Bruin, T.W.A. (193) 137 205 Wahle, K.W.J., see Brown, J.E. (193) 147 Reduction of urinary bile alcohol excretion Waldherr, R., see Raedsch, R. (193) 49 and serum cholestanol in patients with Walker, S., see Raedsch, R. (193) 49 cerebrotendinous xanthomatosis after oral Walrecht, H., see Wolthers, B.G. (193) 113 administration of deoxycholic acid (193) 113 Wolthers, B.G., Van der Molen, J.C., Walrecht, Wong, E., see Thompson, S. (193) 13 H. and Hesselmans, L.F.G.M. Clinica Chimica Acta, Vol. 193 Subject index Activation energy Fucose; Lectin; Ovarian cancer (Thompson, S. Creatine kinase; Glasgow Outcome Scale; Head (193) 13) trauma (Delanghe, J.R. (193) 125) Blood- Alcoholic cirrhosis of the liver Fish-oil; Antioxidant; Lipid peroxidation; Iron; Biliary excretion (Raedsch, R. (193) 49) Plasma insulin; Human subjects (Brown, J.E. (193) 147) Allopurinol Ethanol; Metabolism; Benzbromarone (Kaneko, Calcium activated neutral protease K. (193) 181) Duchenne muscular dystrophy; Protein kinase C; Protein kinase A (Jagadeesh, G. (193) 79) Alpha-1-Proteinase inhibitor Blood; Electrophoresis; Fucose; Lectin; Ovarian Cerebrotendinous xanthomatosis cancer (Thompson, S. (193) 13) Urinary bile alcohol; Serum cholestanol; De- oxycholic acid therapy (Wolthers, B.G. (193) 113) Antidote Pralidoxime chloride; Spectrophotometric de- C1 inhibitor termination; Pralidoxime-Pd(II) complex; Urine Atherosclerosis; Kallikrein; Combined hyper- (Karljikovié-Raji¢, K.D. (193) 119) lipidemia; LDL; Estrogens (De Bruin, T.W.A. (193) 137) Antioxidant Fish-oil; Lipid peroxidation; Blood-aggregation; Collagen Plasma insulin; Human subjects (Brown, J.E. Normal vein; Varicose vein (Maurel, E. (193) 27) (193) 147) Combined hyperlipidemia Atherosclerosis Atherosclerosis; Kallikrein; LDL; C1 inhibitor; Kallikrein; Combined hyperlipidemia; LDL; C1 Estrogens (De Bruin, T.W.A. (193) 137) inhibitor; Estrogens (De Bruin, T.W.A. (193) 137) Creatine kinase Activation energy; Glasgow Outcome Scale; Autoantibody Head trauma (Delanghe, J.R. (193) 125) Lactate dehydrogenase; Radial immunodiffusion; Immunoelectrophoresis (Harff, G.A. (193) Deoxycholic acid therapy 157) Cerebrotendinous xanthomatosis; Urinary bile alcohol; Serum cholestanol (Wolthers, B.G. (193) Benzbromarone 113) Ethanol; Metabolism; Allopurinol (Kaneko, K. (193) 181) Disease activity Rheumatoid arthritis; Hyaluronic acid (Kont- Biliary excretion tinen, Y.T. (193) 39) Iron; Alcoholic cirrhosis of the liver (Raedsch, R. (193) 49) Duchenne muscular dystrophy Calcium activated neutral protease; Protein Blood kinase C; Protein kinase A (Jagadeesh, G. (193) Alpha-1-Proteinase inhibitor; Electrophoresis; 79) Infection diagnosis Alpha-1-Proteinase inhibitor; Blood; Fucose; PMN-elastase; Neonatal sepsis; Newborn; Neo- Lectin; Ovarian cancer (Thompson, S. (193) 13) natal disorder (Tsaka, T. (193) 103) Estrogens lon-pair Atherosclerosis; Kallikrein; Combined hyper- Tyrosine-O-sulfate; Reverse-phase; HPLC (Sui- lipidemia; LDL; C1 inhibitor (De Bruin, T.W.A. ko, M. (193) 193) (193) 137) Iron Ethanol Alcoholic cirrhosis of the liver; Biliary excretion Metabolism; Allopurinol; Benzbromarone (Ka- (Raedsch, R. (193) 49) neko, K. (193) 181) Kallikrein Familial hyperchol lemi Atherosclerosis; Combined hyperlipidemia; Lipoprotein particle; LDL apheresis (Gairin, D. LDL; C1 inhibitor; Estrogens (De Bruin, T.W.A. (193) 165) (193) 137) Fish-oil Lactate dehydrogenase Antioxidant; Lipid peroxidation; Blood-aggrega- Autoantibody; Radial immunodiffusion; Im- tion; Plasma insulin; Human subjects (Brown, munoelectrophoresis (Harff, G.A. (193) 157) J.E. (193) 147) LDL Fucose Atherosclerosis; Kallikrein; Combined hyper- Alpha-1-Proteinase inhibitor; Blood; Electro- lipidemia; C1 inhibitor; Estrogens (De Bruin, phoresis; Lectin; Ovarian cancer (Thompson, S. T.W.A. (193) 137) (193) 13) LDL apheresis Glasgow Outcome Scale Lipoprotein particle, Familial hypercholestero- Creatine kinase; Activation energy; Head trauma lemia (Gairin, D. (193) 165) (Delanghe, J.R. (193) 125) Lectin Glucose, electrochemical assay of Alpha-1-Proteinase inhibitor; Blood; Electro- Redox potentiometric electrode; Nernst equa- phoresis; Fucose; Ovarian cancer (Thompson, S. tion; Oxidase activity (Chen, P.T. (193) 187) (193) 13) Head trauma Lipid peroxidation Creatine kinase; Activation energy; Glasgow Fish-oil; Antioxidant; Blood-aggregation; Plas- Outcome Scale (Delanghe, J.R. (193) 125) ma insulin; Human subjects (Brown, J.E. (193) 147) HPLC Tyrosine-O-sulfate; lon-pair; Reverse-phase Lipoprotein particle (Suiko, M. (193) 193) Familial hypercholesterolemia; LDL apheresis (Gairin, D. (193) 165) Human subjects Fish-oil; Antioxidant; Lipid peroxidation; Metabolism Blood-aggregation; Plasma insulin (Brown, J.E. Ethanol; Allopurinol; Benzbromarone (Kaneko, (193) 147) K. (193) 181) Hyaluronic acid Methodology Rheumatoid arthritis; Disease activity (Kont- Whole-blood versus serum oxalate (Hatch, M. tinen, Y.T. (193) 39) (193) 199) rT 1 . . Neonatal disorder Lactate dehydrogenase; Autoantibody; Radial PMN-elastase; Neonatal sepsis; Infection diag- immunodiffusion (Harff, G.A. (193) 157) nosis; Newborn (Tsaka, T. (193) 103) 208 Neonatal sepsis Pralidoxime chloride PMN-elastase; Infection diagnosis; Newborn; Antidote; Spectrophotometric determination; Neonatal disorder (Tsaka, T. (193) 103) Pralidoxime-Pd(II) complex; Urine (Karljikovi¢- Rajié, K.D. (193) 119) Nernst equation Redox potentiometric electrode; Glucose, elec- Pralidoxime-Pd(II) complex trochemical assay of; Oxidase activity (Chen, Pralidoxime chloride; Antidote; Spectrophoto- P.T. (193) 187) metric determination; Urine (Karljikovi¢-Raji¢, K.D. (193) 119) Newborn PMN-elastase; Neonatal sepsis; Infection diag- Protein kinase A nosis; Neonatal disorder (Tsaka, T. (193) 103) Duchenne muscular dystrophy; Calcium activated neutral protease; Protein kinase C (Jaga- Normal vein deesh, G. (193) 79) Varicose vein; Collagen (Maurel, E. (193) 27) Protein kinase C Oligoclonal immunoglobulin Duchenne muscular dystrophy; Calcium activa- Rheumatoid arthritis; Synovial fluid (Carpenter, ted neutral protease; Protein kinase A A.B. (193) 1) (Jagadeesh, G. (193) 79) Ovarian cancer Purification Alpha-1-Proteinase inhibitor; Blood; Electro- Phenylalanine hydroxylase; Polyclonal antibod- phoresis; Fucose; Lectin (Thompson, S. (193) ies; Western blot (Petruschka, L. (193) 65) 13) Radial immunodiffusion Oxidase activity Lactate dehydrogenase; Autoantibody; Immuno- Redox potentiometric electrode; Nernst equa- electrophoresis (Harff, G.A. (193) 157) tion; Glucose, electrochemical assay of (Chen, P.T. (193) 187) Redox potentiometric electrode Nernst equation; Glucose, electrochemical assay Parathyroidectomy of; Oxidase activity (Chen, P.T. (193) 187) Parathyroid hormone; Renal osteodystrophy (Straffen, A.M. (193) 55) Renal osteodystrophy Parathyroid hormone; Parathyroidectomy (Straf- Parathyroid hormone fen, A.M. (193) 55) Renal _ osteodystrophy; Parathyroidectomy (Straffen, A.M. (193) 55) Reverse-phase Tyrosine-O-sulfate; lon-pair; HPLC (Suiko, M. Phenylalanine hydroxylase (193) 193) Purification; Polyclonal antibodies; Western blot (Petruschka, L. (193) 65) Rheumatoid arthritis Synovial fluid; Oligoclonal immunoglobulin Plasma insulin (Carpenter, A.B. (193) 1) Fish-oil; Antioxidant; Lipid peroxidation; Blood-aggregation; Human subjects (Brown, J.E. Hyaluronic acid; Disease activity (Konttinen, (193) 147) Y.T. (193) 39) PMN-elastase Serum cholestanol Neonatal sepsis; Infection diagnosis; Newborn; Cerebrotendinous xanthomatosis; Urinary bile Neonatal disorder (Tsaka, T. (193) 103) alcohol; Deoxycholic acid therapy (Wolthers, B.G. (193) 113) Polyclonal antibodies Phenylalanine hydroxylase; Purification; West- Spectrophotometric determination ern blot (Petruschka, L. (193) 65) Pralidoxime chloride; Antidote; Pralidoxime- Pd(Il) complex; Urine (Karljikovié-Raji¢é, K.D. Urine (193) 119) Pralidoxime chloride; Antidote; Spectrophoto- metric determination; Pralidoxime-Pd(II) com- Synovial fluid plex (Karljikovié-Raji¢, K.D. (193) 119) Rheumatoid arthritis; Oligoclonal immunoglobulin (Carpenter, A.B. (193) 1) Varicose vein Normal vein; Collagen (Maurel, E. (193) 27) Tyrosine-O -sulfate lon-pair; Reverse-phase,; HPLC (Suiko, M. (193) Western blot 193) Phenylalanine hydroxylase; Purification; Poly- clonal antibodies (Petruschka, L. (193) 65) Urinary bile alcohol Cerebrotendinous xanthomatosis; Serum choles- Whole-blood versus serum oxalate tanol; Deoxycholic acid therapy (Wolthers, B.G. Methodology (Hatch, M. (193) 199) (193) 113)